SERES THERAPEUTICS INC (MCRB) Stock Price, Quote, News and Overview
NASDAQ:MCRB - Nasdaq - US81750R1023 - Common Stock - Currency: USD
MCRB Quote, Performance and Key Statistics
SERES THERAPEUTICS INC
NASDAQ:MCRB (2/4/2025, 8:00:00 PM)
After market: 0.8284 +0.02 (+2.83%)0.8056
-0.03 (-3.02%)
The current stock price of MCRB is 0.8056 USD. In the past month the price decreased by -11.02%. In the past year, price decreased by -28.07%.
MCRB Latest News, Press Releases and Analysis
Let's take a look at the stocks that are in motion in today's session.
Top movers in Wednesday's session
Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale
CAMBRIDGE, Mass., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics...
Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates
New SER-155 Phase 1b study biomarker data in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients demonstrate that SER-155 promoted...
Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that...
FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)
Designation based on encouraging Phase 1b clinical data, including that SER-155 resulted in a 77% relative risk reduction in bacterial bloodstream...
MCRB Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.77 | 335.67B | ||
| AMGN | AMGEN INC | 15.04 | 155.36B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 945.65 | 124.20B | ||
| GILD | GILEAD SCIENCES INC | 22.12 | 122.12B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.60B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.95B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.95B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.08B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.76B | ||
| NTRA | NATERA INC | N/A | 23.00B | ||
| BIIB | BIOGEN INC | 8.73 | 20.76B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.52 | 15.78B |
Related stock screener links
About MCRB
Company Profile
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. The company is headquartered in Cambridge, Massachusetts and currently employs 233 full-time employees. The company went IPO on 2015-06-26. The firm is engaged in developing SER-155, which has demonstrated a significant reduction in bloodstream infections and related complications (as compared to placebo) in a clinical study in patients undergoing allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT). The firm is also advancing additional cultivated oral live biotherapeutics for medically vulnerable populations, including those with chronic liver disease, cancer neutropenia, and solid organ transplants. The firm's clinical and nonclinical data across its programs support the development of live biotherapeutics to target the prevention and treatment of a broad swath of infections, and in inflammatory and immune diseases.
Company Info
SERES THERAPEUTICS INC
101 Cambridge Park Drive
Cambridge MASSACHUSETTS 02139 US
CEO: Eric D. Shaff
Employees: 233
Company Website: https://www.serestherapeutics.com/
Investor Relations: https://ir.serestherapeutics.com
Phone: 16179459626
MCRB FAQ
What is the stock price of MCRB?
The current stock price of MCRB is 0.8056 USD.
What is the symbol for SERES THERAPEUTICS INC stock?
The exchange symbol of SERES THERAPEUTICS INC is MCRB and it is listed on the Nasdaq exchange.
On which exchange is MCRB stock listed?
MCRB stock is listed on the Nasdaq exchange.
Is MCRB a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for MCRB, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of MCRB.
Does MCRB stock pay dividends?
MCRB does not pay a dividend.
What is the Price/Earnings (PE) ratio of MCRB?
MCRB does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.19).
What is the Short Interest ratio of MCRB stock?
The outstanding short interest for MCRB is 13.69% of its float.
MCRB Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to MCRB. When comparing the yearly performance of all stocks, MCRB is a bad performer in the overall market: 75.5% of all stocks are doing better.
MCRB Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MCRB. MCRB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
MCRB Financial Highlights
Over the last trailing twelve months MCRB reported a non-GAAP Earnings per Share(EPS) of -1.19. The EPS decreased by -6.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -14.25% | ||
| ROE | -106.51% | ||
| Debt/Equity | 0 |
MCRB Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 75% to MCRB. The Buy consensus is the average rating of analysts ratings from 13 analysts.
For the next year, analysts expect an EPS growth of 87.91% and a revenue growth -100% for MCRB